Literature DB >> 29333670

Pustular psoriasis and related pustular skin diseases.

H Bachelez1,2,3.   

Abstract

Patients with pustular psoriasis or related pustular diseases may have genetic abnormalities impairing the function of key players of the innate skin immune system. Recently, identification of these abnormalities has changed the paradigm of several of these diseases. These include generalized pustular psoriasis, palmoplantar pustular psoriasis and acrodermatitis continua of Hallopeau, and also drug-induced acute exanthematous generalized pustular eruption. Identified mutations in IL36RN, CARD14 and AP1S3 in different groups of patients lead to enhanced inflammatory cascade in several cellular subtypes including keratinocytes, and to the recruitment and activation of neutrophils and macrophages. These insights have unveiled pathophysiological features that shift the existing paradigms and emphasize the autoinflammatory nature of skin pustular disorders. They also highlight the crucial role of the innate immune system across entities belonging to the psoriasis disease spectrum, allowing identification of new appealing therapeutic targets.
© 2018 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29333670     DOI: 10.1111/bjd.16232

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Innovations in Psoriasis Management: Based on Selected Presentations from the Symposium for Cosmetic Advances & Laser Education (SCALE) Virtual Congress-July 24 to 26, 2020.

Authors:  Jo Ann Lequang
Journal:  J Clin Aesthet Dermatol       Date:  2020-11-01

2.  Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau.

Authors:  Giulio Rizzetto; Federico Diotallevi; Elisa Molinelli; Giulia Radi; Anna Maria Offidani
Journal:  Skin Appendage Disord       Date:  2021-09-17

Review 3.  Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.

Authors:  Marco Galluzzo; Simone D'Adamio; Miriam Teoli; Luca Bianchi; Marina Talamonti
Journal:  Dermatol Ther       Date:  2019-04-29       Impact factor: 2.851

4.  Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.

Authors:  Siew Eng Choon; Mark G Lebwohl; Slaheddine Marrakchi; A David Burden; Tsen-Fang Tsai; Akimichi Morita; Alexander A Navarini; Min Zheng; Jinhua Xu; Hamida Turki; Sushmita Rajeswari; Hongjie Deng; Kay Tetzlaff; Christian Thoma; Hervé Bachelez
Journal:  BMJ Open       Date:  2021-03-30       Impact factor: 2.692

Review 5.  Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.

Authors:  Alan Menter; Abby S Van Voorhees; Sylvia Hsu
Journal:  Dermatol Ther (Heidelb)       Date:  2021-10-09

6.  Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis.

Authors:  Theresa Benezeder; Clemens Painsi; VijayKumar Patra; Saptaswa Dey; Martin Holcmann; Bernhard Lange-Asschenfeldt; Maria Sibilia; Peter Wolf
Journal:  Elife       Date:  2020-06-02       Impact factor: 8.140

Review 7.  The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis.

Authors:  Michael P Schön; Luise Erpenbeck
Journal:  Front Immunol       Date:  2018-06-15       Impact factor: 7.561

Review 8.  Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease.

Authors:  Laura Israel; Mark Mellett
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

9.  Acrodermatitis continua of Hallopeau: clinical perspectives.

Authors:  Mary Patricia Smith; Karen Ly; Quinn Thibodeaux; Tina Bhutani; Wilson Liao; Kristen M Beck
Journal:  Psoriasis (Auckl)       Date:  2019-08-09

10.  New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019.

Authors:  Regine J Mathieu; Caryn B C Cobb; Gladys H Telang; Elnaz F Firoz
Journal:  JAAD Case Rep       Date:  2020-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.